Bard J. Geesaman
Chief Tech/Sci/R&D Officer presso Acylin Therapeutics, Inc.
Profilo
Bard J.
Geesaman is the founder of Solasia Pharma KK, which was founded in 2006.
He is also the founder of TriNetX, LLC, Catalyst Medical Solutions, Inc...
Dr. Geesaman's current job(s) include being a Director at Informed Medical Decisions, Inc., Rekindle Therapeutics, Inc., and Acylin Therapeutics, Inc. He is also a General Partner at F3 Ventures Ltd.
since 2015.
Dr. Geesaman's former job(s) include being a Director at ProterixBio, Inc., an Independent Director at Chiasma, Inc., a Director at Clinical Ink, Inc., a Managing Director at MPM BioImpact, Inc., an Executive Director-Life Sciences Division at X PRIZE Foundation, a Director at Maverick Therapeutics, Inc., a Vice President-Medical Development at Elixir Pharmaceuticals, Inc. from 2003 to 2007, a General Partner at F2 Capital Ventures LLP in 2000, a Chief Scientific Officer at PharmSelex Corp., and a Member-Supervisory Board at iOmx Therapeutics AG.
Dr. Geesaman's education history includes a doctorate from Massachusetts Institute of Technology, an undergraduate degree from the University of California, Berkeley, and a doctorate from Harvard Medical School.
Posizioni attive di Bard J. Geesaman
| Società | Posizione | Inizio |
|---|---|---|
F3 Ventures Ltd.
 F3 Ventures Ltd. Miscellaneous Commercial ServicesCommercial Services F3 Ventures Ltd. provides management consulting services. The company was founded by William James Davies and Frederick Glyn Davies on February 23, 2005 and is headquartered in Stowmarket, the United Kingdom. | Corporate Officer/Principal | - |
Acylin Therapeutics, Inc.
 Acylin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acylin Therapeutics, Inc. develops drugs for cancer. The company was founded by Philip A. Cole, Peter S. DiStefano, Ronen Marmorstein, Suresh K. Jain and Roydon Price in 2009 and is headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | - |
Informed Medical Decisions, Inc.
 Informed Medical Decisions, Inc. Medical/Nursing ServicesHealth Services Informed Medical Decisions, Inc. provides professional and networking services. The firm operates as a comprehensive evidence-based knowledge library for genetic tests and hereditary conditions. It offers information about the genetic counseling services to both consumers and medical providers, and how to initiate services. The company was founded by David Patrick Nixon, Heather L. Shappell, and Rebecca Sutphen in 2007 and is headquartered in St. Petersburg, FL. | Director/Board Member | - |
Rekindle Therapeutics, Inc.
 Rekindle Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rekindle Therapeutics, Inc. operates as an biotechnology company. The company is headquartered in Cambridge, MA. | Director/Board Member | - |
Precedenti posizioni note di Bard J. Geesaman
| Società | Posizione | Fine |
|---|---|---|
PharmSelex Corp.
 PharmSelex Corp. Pharmaceuticals: MajorHealth Technology PharmSelex Corp. (formerly GPC-Rx) focuses on the structure prediction of G-protein coupled receptors (GPCRs) to develop new GPCR-targeting drugs with reduced toxicity and enhanced selectivity. PharmSelex’s technology was developed in the laboratory of Dr. William Goddard at California Institute of Technology. The company is located in Seattle, Washington. | Chief Tech/Sci/R&D Officer | 30/12/2010 |
Elixir Pharmaceuticals, Inc.
 Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2007 |
F2 Capital Ventures LLP
 F2 Capital Ventures LLP Investment ManagersFinance F2 Capital Ventures LLP (F2 Ventures) is an Independent Venture Capital firm founded in 2003 by Morana Jovan-Embiricos. The firm is headquartered in the UK. | Corporate Officer/Principal | 31/12/2000 |
| Catalyst Medical Solutions, Inc. | Founder | - |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Director/Board Member | - |
Formazione di Bard J. Geesaman
| Massachusetts Institute of Technology | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SOLASIA PHARMA K.K. | Health Technology |
| Aziende private | 16 |
|---|---|
ProterixBio, Inc.
 ProterixBio, Inc. Medical SpecialtiesHealth Technology ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA. | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA. | Health Technology |
Clinical Ink, Inc.
 Clinical Ink, Inc. Internet Software/ServicesTechnology Services Clinical Ink, Inc. provides electronic source solutions for clinical research sites. Its solutions include data management, monitoring, clinical sites and patient centric. The company was founded by Douglas E. Pierce Jr. and Tommy Littlejohn on July 19, 2006 and is headquartered in Winston-Salem, NC. | Technology Services |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | Miscellaneous |
X PRIZE Foundation
 X PRIZE Foundation Miscellaneous Commercial ServicesCommercial Services X PRIZE Foundation creates educational programming for students and space enthusiasts. It offers services in space and ocean exploration, life sciences, energy and environment, education, and global development areas. The company was founded by Peter Diamandis in 1995 and is headquartered in Santa Monica, CA. | Commercial Services |
F2 Capital Ventures LLP
F2 Capital Ventures LLP Investment ManagersFinance F2 Capital Ventures LLP (F2 Ventures) is an Independent Venture Capital firm founded in 2003 by Morana Jovan-Embiricos. The firm is headquartered in the UK. | Finance |
PharmSelex Corp.
PharmSelex Corp. Pharmaceuticals: MajorHealth Technology PharmSelex Corp. (formerly GPC-Rx) focuses on the structure prediction of G-protein coupled receptors (GPCRs) to develop new GPCR-targeting drugs with reduced toxicity and enhanced selectivity. PharmSelex’s technology was developed in the laboratory of Dr. William Goddard at California Institute of Technology. The company is located in Seattle, Washington. | Health Technology |
Acylin Therapeutics, Inc.
Acylin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acylin Therapeutics, Inc. develops drugs for cancer. The company was founded by Philip A. Cole, Peter S. DiStefano, Ronen Marmorstein, Suresh K. Jain and Roydon Price in 2009 and is headquartered in Seattle, WA. | Health Technology |
Informed Medical Decisions, Inc.
Informed Medical Decisions, Inc. Medical/Nursing ServicesHealth Services Informed Medical Decisions, Inc. provides professional and networking services. The firm operates as a comprehensive evidence-based knowledge library for genetic tests and hereditary conditions. It offers information about the genetic counseling services to both consumers and medical providers, and how to initiate services. The company was founded by David Patrick Nixon, Heather L. Shappell, and Rebecca Sutphen in 2007 and is headquartered in St. Petersburg, FL. | Health Services |
F3 Ventures Ltd.
F3 Ventures Ltd. Miscellaneous Commercial ServicesCommercial Services F3 Ventures Ltd. provides management consulting services. The company was founded by William James Davies and Frederick Glyn Davies on February 23, 2005 and is headquartered in Stowmarket, the United Kingdom. | Commercial Services |
TriNetX, LLC
 TriNetX, LLC Medical/Nursing ServicesHealth Services TriNetX, Inc. provides an online data network for collaborative research. It enables hospitals, academic medical centers, physician networks, practices, and pharmaceuticals to participate in collaborative research and a public and private sustainability model for research informatics. The company was founded by Bard Geesaman in 2013 and is headquartered in Cambridge, MA. | Health Services |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Health Technology |
| Catalyst Medical Solutions, Inc. | |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Health Technology |
Rekindle Therapeutics, Inc.
Rekindle Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rekindle Therapeutics, Inc. operates as an biotechnology company. The company is headquartered in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Bard J. Geesaman
